Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Oleg A. Shukhov"'
Autor:
Ekaterina Yu. Chelysheva, Anna N. Petrova, Oleg A. Shukhov, Anastasiia V. Bykova, Irina S. Nemchenko, Margarita A. Gurianova, Nikolay N. Tsyba, Anna G. Turkina
Publikováno v:
Терапевтический архив, Vol 94, Iss 7, Pp 836-843 (2022)
Background. Withdrawal syndrome (WS) a musculoskeletal pain after discontinuation of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukemia (CML) has been described in the treatment-free remission (TFR) studies. The pathophysiolog
Externí odkaz:
https://doaj.org/article/3431c71bb243457c9d5695396a2d723c
Autor:
Alexander V. Lavrov, Ekaterina Yu. Chelysheva, Elmira P. Adilgereeva, Oleg A. Shukhov, Svetlana A. Smirnikhina, Konstantin S. Kochergin-Nikitsky, Valentina D. Yakushina, Grigory A. Tsaur, Sergey V. Mordanov, Anna G. Turkina, Sergey I. Kutsev
Publikováno v:
BMC Medical Genomics, Vol 12, Iss S2, Pp 5-13 (2019)
Abstract Background Approximately 5–20% of chronic myeloid leukemia (CML) patients demonstrate primary resistance or intolerance to imatinib. None of the existing predictive scores gives a good prognosis of TKI efficacy. Gene polymorphisms, express
Externí odkaz:
https://doaj.org/article/65b6107f1bb54961af0fe7269e7108aa
Publikováno v:
Эндокринная хирургия, Vol 12, Iss 3, Pp 140-149 (2018)
Background. The effective treatment of the hand-foot syndrome is a necessary component of the complex treatment of patients receiving antitumor therapy with multikinase inhibitors. Aims. The assessment of a new effective method for the treatment o
Externí odkaz:
https://doaj.org/article/524a4e37c0f94996b644a8df43dd0ae1
Autor:
Anna Turkina, Elena A. Kuzmina, Elza Lomaia, Elena Morozova, Oleg A. Shukhov, Anna N. Petrova, Tamara Chitanava, Julia J. Vlasova, Ekaterina Yu. Chelysheva, Evgeniya Sbityakova, Irina S. Nemchenko, Anastasiya V. Bykova, Margarita A. Gurianova, Alina V. Kokhno, Elena N. Parovichnikova
Publikováno v:
Blood. 140:9654-9655
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16768c8d0c1d6f252f4a812c425726e2
https://doi.org/10.1182/blood-2022-162268
https://doi.org/10.1182/blood-2022-162268
Autor:
Alexander V Lavrov, Oksana A Ustaeva, Elmira P Adilgereeva, Svetlana A Smirnikhina, Ekaterina Y Chelysheva, Oleg A Shukhov, Yuriy V Shatokhin, Sergey V Mordanov, Anna G Turkina, Sergey I Kutsev
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0182901 (2017)
Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the presence of BCR/ABL fusion gene in leukemic cells, which promotes uncontrolled cell proliferation. Up to 20% of CML patients show primary resistance or non-optimal re
Externí odkaz:
https://doaj.org/article/aebeca0cfcc84482b693b260ee7cce6c